Biotech

All Articles

Orion to utilize Aitia's 'electronic twins' to find brand new cancer cells medicines

.Finnish biotech Orion has spied potential in Aitia's "electronic twin" specialist to create brand-n...

Windtree's shock med brings up blood pressure in newest period 2 gain

.While Windtree Therapeutics has battled to increase the financial roots required to survive, a stag...

2 cancer biotechs merge, making international footprint

.OncoC4 is taking AcroImmune-- as well as its own internal scientific manufacturing functionalities-...

Amgen files very first phase 3 gain for $400M dermatitis drug

.Amgen has actually discussed (PDF) the very first period 3 data on its own $400 thousand dermatitis...

Biogen, UCB report phase 3 lupus win after neglecting earlier test

.Biogen and also UCB's depend advancing in to period 3 on the back of a failed study hopes to have s...

Aptadir hopes brand new RNA preventions may turn around challenging cancers cells

.Italian biotech Aptadir Therapies has released with the promise that its own pipeline of preclinica...

Wave surfs DMD effectiveness to regulatory authorities' doors, delivering stock up

.Surge Lifestyle Sciences has actually met its own target in a Duchenne muscle dystrophy (DMD) study...

Sanofi picks new CSO coming from in-stealth biotech

.After a few years in biotech, Mike Quigley, Ph.D., is returning to the pharma crease, using up the ...

Achilles trickles tissue treatment plan, bandages for unemployments after skipping 'commercial stability' goals

.Achilles Rehabs has actually torn up its strategy. The British biotech is quiting working on its cl...

Aligos proclaims stage 2 MASH win, reducing liver fat approximately 46%

.Aligos Therapeutics is heralding a midstage succeed in metabolic-dysfunction connected steatohepati...